We are live on
!
Find out more
IA
Investor AB Portfolio holdings
AUM
$15.1B
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.35%
1 Year Est. Return
+29.02%
3 Year Est. Return
+79.02%
5 Year Est. Return
+98.76%
10 Year Est. Return
+341.52%
AUM
$1.12B
AUM Growth
+$85.2M
(+8.2%)
Cap. Flow
-$1.27M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carnival Corporation Ltd
CCL
|
+$585K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$1.32M |
| 2 |
Carlyle Group
CG
|
+$532K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 88.42% |
| 2 | Technology | 3.22% |
| 3 | Healthcare | 1.55% |
| 4 | Consumer Discretionary | 0.06% |
Similar funds
MSV
AT
UM
RFC
FCAS
GF
Investor AB's Q1 2015 Portfolio in Review
As of Q1 2015, Investor AB held 9 positions worth $1.12B, up 8.2% from $1.03B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Investor AB's Q1 2015 filing shows 1 new and 2 reduced positions. Its largest new stake was Carnival Corporation Ltd: 13,000 shares worth $622K. The largest sale was Corcept Therapeutics, an estimated $1.32M.
By sector, the portfolio is most concentrated in Financials at 88% of assets, down from 90% a quarter earlier, followed by Technology and Healthcare.
- Investor AB's largest Q1 2015 buy was Carnival Corporation Ltd: 13,000 shares worth $622K.
- Investor AB's biggest Q1 2015 reduction was Corcept Therapeutics, cutting an estimated $1.32M.
- Investor AB's ten largest holdings make up 100% of its $1.12B portfolio in Q1 2015.
- Investor AB opened 1 new position and closed 0 in Q1 2015.
- Investor AB's portfolio value rose 8.2% quarter-over-quarter to $1.12B.
Based on Investor AB's 13F filing for Q1 2015, filed 15 May 2015.